Evidence map›Paper›PMID 41590419›Full record

ReviewJournal of fungi (Basel, Switzerland)2025

Development of Mycoinsecticides: Advances in Formulation, Regulatory Challenges and Market Trends for Entomopathogenic Fungi.

Joel C Couceiro, Martyn J Wood, Andronikos Papadopoulos, Juan J Silva, John Vontas, George Dimopoulos

Abstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Endophytic entomopathogenic fungi: The next frontier in mycological biocontrol.World journal of microbiology & biotechnology · 2026
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joel C CouceiroInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (IMBB-FORTH), Nikolaou Plastira 100, GR-70013 Heraklion, Greece.ORCID 0000-0003-1433-3554
Martyn J WoodInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (IMBB-FORTH), Nikolaou Plastira 100, GR-70013 Heraklion, Greece.ORCID 0000-0002-3229-7932
Andronikos PapadopoulosInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (IMBB-FORTH), Nikolaou Plastira 100, GR-70013 Heraklion, Greece.ORCID 0009-0009-4130-8435
Juan J SilvaInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (IMBB-FORTH), Nikolaou Plastira 100, GR-70013 Heraklion, Greece.ORCID 0000-0003-0148-1988
John VontasInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (IMBB-FORTH), Nikolaou Plastira 100, GR-70013 Heraklion, Greece.ORCID 0000-0002-8704-2574
George DimopoulosInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (IMBB-FORTH), Nikolaou Plastira 100, GR-70013 Heraklion, Greece.ORCID 0000-0001-6755-8111

Funding

Bloomberg Philanthropies N/AEuropean Union's HORIZON-CSA (HORIZON-WIDERA-2022-TALENTS-01-ERA Chairs) programme 101087110
6 · The paper itself

Abstract

Bioinsecticides offer eco-friendly alternatives to chemical insecticides and thereby meet the need for sustainable pest control. Entomopathogenic fungi (EPF) represent one of the core classes of microbial insecticides, distinguished by their advantageous contact-based mode of action. Several products have been successfully commercialized, and with continuing improvements to the technology, the market size for EPF continues to grow. The translation of EPF into reliable field performers relies upon formulation technologies that ensure product quality, stability, virulence, and cost-effectiveness. Current formulations comprise diverse solid and liquid states (e.g., wettable powders, oil dispersions) that deliver a range of propagules (conidia, blastospores, microsclerotia). While advanced approaches like nanoparticle encapsulation show promise, some limitations hinder their widespread use. Major constraints include maintaining fungal viability during storage/transport and protecting propagules from harsh environmental factors post-application. Regulatory requirements also present significant barriers to widespread uptake. Addressing these formulation challenges through continued research is essential for advancing mycoinsecticide technology and increasing their contribution to integrated pest management. This review aims to present the latest scientific advances in EPF formulation technologies and application strategies, alongside an overview of current regulatory frameworks and an up-to-date analysis of registered microbial biopesticide products in some of the world's largest markets.

Indexed as

entomopathogenic fungiformulationmicrobial controlmycoinsecticides

Identifiers

PMID41590419
PMCPMC12843292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.